The National Academies Press

Currently Skimming:

Appendix B: Agenda
Pages 497-500

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 497... ... Appendix B Agenda Microbial Ecology in States of Health and Disease March 18–19, 2013 500 Fifth Street, NW Washington DC DAY ONE: MONDAY, MARCH 18, 2013 7:30–8:00: Registration and Continental Breakfast 8:00–8:15: Welcoming Remarks: David Relman, James Hughes, and Lonnie King KEYNOTE: Indigenous microbes and the ecology of chronic 8:15–9:00: diseases Martin Blaser, New York University 9:00–9:15: Discussion 9:15–9:30: BREAK 497 Read the entire page →
From page 498... ... 498 MICROBIAL ECOLOGY IN STATES OF HEALTH AND DISEASE Session I: HOST–MICROBE INTERACTIONS IN HUMANS, ANIMALS, AND PLANTS Moderator: Rima Khabbaz, Centers for Disease Control and Prevention 9:30–10:00: Plant–microbe interactions in root endophyte and rhizosphere communities of Populus Gerald Tuskan, Oak Ridge National Laboratory 10:00–10:30: Origins and maintenance of host–microbe interactions Angela Douglas, Cornell University 10:30–11:00: Annual cycles of extreme dietary change shape gut microbiota and their hibernator hosts Hannah Carey, University of Wisconsin, Madison 11:00–11:30: Symbiont microbiota and the development and maturation of the mammalian immune system Gérard Eberl, Pasteur Institute 11:30–12:00: Discussion 12:00–1:00: LUNCH SESSION II: emerging insights into host–microbe interactions Moderator: David Relman, Stanford University 1:00–1:30: Community ecology and the human vaginal microbiome Larry Forney, University of Idaho 1:30–2:00: Host defense and immunomodulation of mucosal candidiasis Paul Fidel, Jr., Louisiana State University 2:00–2:30: Interactions between the mammalian virome, disease susceptibility genes, and the phenome Herbert "Skip" Virgin, Washington University 2:30–3:00: BREAK Microbial community dynamics and disruption -- Health and 3:00–3:30: disease in coral reefs and the human lung Forest Rohwer, San Diego State University Read the entire page →
From page 499... ... APPENDIX B 499 3:30–4:00: Interactions and functions of the gut microbiota in a model vertebrate host Karen Guillemin, University of Oregon 4:00–4:30: The influence of the mucosal immune system and gut microbiota on inflammatory bowel diseases (IBDs) Richard Blumberg, Harvard Medical School 4:30–5:30: Discussion 5:30–6:00: Concluding Remarks 6:00: ADJOURN DAY ONE DAY TWO: TUESDAY, March 19, 2013 8:00–8:30: Registration and Continental Breakfast 8:30–8:45: Welcoming Remarks and Summary of Day One: David Relman SESSION III: STRUCTURE AND FUNCTION OF HOST ASSOCIATED MICROBIAL COMMUNITIES Moderator: Queta Bond, Burroughs Wellcome Fund 8:45–9:15: The application of ecological concepts to host-associated microbial communities Brendan Bohannan, University of Oregon 9:15–9:45: Nutrition and the infant gut microbiota -- Health and disease in the first 1,000 days David Mills, University of California, Davis 9:45–10:15: Roles of the microbiota in the control and pathogenesis of infections Yasmine Belkaid, National Institute of Allergy and Infectious Diseases 10:15–10:45: BREAK 10:45–11:15: Host–microbe interactions and the genetic architecture of IBD and other complex diseases Ramnik Xavier, Massachusetts General Hospital Read the entire page →
From page 500... ... 500 MICROBIAL ECOLOGY IN STATES OF HEALTH AND DISEASE 11:15–11:45: Host–mycobiome interactions in gut homeostasis and pathogenesis David Underhill, Cedars-Sinai Medical Center 11:45–12:15: Discussion 12:15–1:15: LUNCH SESSION IV: RESEARCH CHALLENGES AND OPPORTUNITIES Moderator: Jesse Goodman, Food and Drug Administration 1:15–1:45: Metabolism, interspecies interactions, and novel approaches to disease diagnostics and treatment Michael Fischbach, University of California, San Francisco 1:45–2:15: Fecal transplantation as a treatment option for recurrent Clostridium difficile infection Keller, University of Amsterdam Josbert J 2:15–2:45: BREAK 2:45–3:15: Innate antimicrobial mechanisms in disease prevention and treatment Michael Zasloff, Georgetown University 3:15–3:45: The skin microbiome and chronic disease states Julie Segre, National Human Genome Research Institute 3:45–4:30: Discussion 4:30–4:45: Concluding Remarks 4:45: ADJOURN Read the entire page →

From page 497...

... Appendix B Agenda Microbial Ecology in States of Health and Disease March 18–19, 2013 500 Fifth Street, NW Washington DC DAY ONE: MONDAY, MARCH 18, 2013 7:30–8:00: Registration and Continental Breakfast 8:00–8:15: Welcoming Remarks: David Relman, James Hughes, and Lonnie King KEYNOTE: Indigenous microbes and the ecology of chronic 8:15–9:00: diseases Martin Blaser, New York University 9:00–9:15: Discussion 9:15–9:30: BREAK 497

Read the entire page →

From page 498...

... 498 MICROBIAL ECOLOGY IN STATES OF HEALTH AND DISEASE Session I: HOST–MICROBE INTERACTIONS IN HUMANS, ANIMALS, AND PLANTS Moderator: Rima Khabbaz, Centers for Disease Control and Prevention 9:30–10:00: Plant–microbe interactions in root endophyte and rhizosphere communities of Populus Gerald Tuskan, Oak Ridge National Laboratory 10:00–10:30: Origins and maintenance of host–microbe interactions Angela Douglas, Cornell University 10:30–11:00: Annual cycles of extreme dietary change shape gut microbiota and their hibernator hosts Hannah Carey, University of Wisconsin, Madison 11:00–11:30: Symbiont microbiota and the development and maturation of the mammalian immune system Gérard Eberl, Pasteur Institute 11:30–12:00: Discussion 12:00–1:00: LUNCH SESSION II: emerging insights into host–microbe interactions Moderator: David Relman, Stanford University 1:00–1:30: Community ecology and the human vaginal microbiome Larry Forney, University of Idaho 1:30–2:00: Host defense and immunomodulation of mucosal candidiasis Paul Fidel, Jr., Louisiana State University 2:00–2:30: Interactions between the mammalian virome, disease susceptibility genes, and the phenome Herbert "Skip" Virgin, Washington University 2:30–3:00: BREAK Microbial community dynamics and disruption -- Health and 3:00–3:30: disease in coral reefs and the human lung Forest Rohwer, San Diego State University

Read the entire page →

From page 499...

... APPENDIX B 499 3:30–4:00: Interactions and functions of the gut microbiota in a model vertebrate host Karen Guillemin, University of Oregon 4:00–4:30: The influence of the mucosal immune system and gut microbiota on inflammatory bowel diseases (IBDs) Richard Blumberg, Harvard Medical School 4:30–5:30: Discussion 5:30–6:00: Concluding Remarks 6:00: ADJOURN DAY ONE DAY TWO: TUESDAY, March 19, 2013 8:00–8:30: Registration and Continental Breakfast 8:30–8:45: Welcoming Remarks and Summary of Day One: David Relman SESSION III: STRUCTURE AND FUNCTION OF HOST ASSOCIATED MICROBIAL COMMUNITIES Moderator: Queta Bond, Burroughs Wellcome Fund 8:45–9:15: The application of ecological concepts to host-associated microbial communities Brendan Bohannan, University of Oregon 9:15–9:45: Nutrition and the infant gut microbiota -- Health and disease in the first 1,000 days David Mills, University of California, Davis 9:45–10:15: Roles of the microbiota in the control and pathogenesis of infections Yasmine Belkaid, National Institute of Allergy and Infectious Diseases 10:15–10:45: BREAK 10:45–11:15: Host–microbe interactions and the genetic architecture of IBD and other complex diseases Ramnik Xavier, Massachusetts General Hospital

Read the entire page →

From page 500...

... 500 MICROBIAL ECOLOGY IN STATES OF HEALTH AND DISEASE 11:15–11:45: Host–mycobiome interactions in gut homeostasis and pathogenesis David Underhill, Cedars-Sinai Medical Center 11:45–12:15: Discussion 12:15–1:15: LUNCH SESSION IV: RESEARCH CHALLENGES AND OPPORTUNITIES Moderator: Jesse Goodman, Food and Drug Administration 1:15–1:45: Metabolism, interspecies interactions, and novel approaches to disease diagnostics and treatment Michael Fischbach, University of California, San Francisco 1:45–2:15: Fecal transplantation as a treatment option for recurrent Clostridium difficile infection Keller, University of Amsterdam Josbert J 2:15–2:45: BREAK 2:45–3:15: Innate antimicrobial mechanisms in disease prevention and treatment Michael Zasloff, Georgetown University 3:15–3:45: The skin microbiome and chronic disease states Julie Segre, National Human Genome Research Institute 3:45–4:30: Discussion 4:30–4:45: Concluding Remarks 4:45: ADJOURN

Read the entire page →

Key Terms

← Previous Chapter Skim

Next Chapter Skim →

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.

Appendix B: Agenda Pages 497-500

Appendix B: Agenda
Pages 497-500